oxybutynin has been researched along with Nervous System Diseases in 4 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Primary outcome: Drooling Impact Scale (DIS) score at week-4." | 2.87 | Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability. ( Cadwgan, J; Cole, M; Colver, AF; O'Hare, AE; Parr, JR; Pennington, L; Stocken, D; Todhunter, E; Tuffrey, C; Williams, J, 2018) |
| " Taking domestic usage by age group into account, there is a disproportionately higher number of CNS adverse event cases reported in pediatric patients as compared with adult patients." | 1.35 | Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases. ( Gish, P; Johann-Liang, R; Mosholder, AD; Truffa, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gish, P | 1 |
| Mosholder, AD | 1 |
| Truffa, M | 1 |
| Johann-Liang, R | 1 |
| Movig, KL | 1 |
| Egberts, AC | 1 |
| Lenderink, AW | 1 |
| Leufkens, HG | 1 |
| Appell, RA | 1 |
| Sand, P | 1 |
| Dmochowski, R | 1 |
| Anderson, R | 1 |
| Zinner, N | 1 |
| Lama, D | 1 |
| Roach, M | 1 |
| Miklos, J | 1 |
| Saltzstein, D | 1 |
| Boone, T | 1 |
| Staskin, DR | 1 |
| Albrecht, D | 1 |
| Parr, JR | 1 |
| Todhunter, E | 1 |
| Pennington, L | 1 |
| Stocken, D | 1 |
| Cadwgan, J | 1 |
| O'Hare, AE | 1 |
| Tuffrey, C | 1 |
| Williams, J | 1 |
| Cole, M | 1 |
| Colver, AF | 1 |
2 trials available for oxybutynin and Nervous System Diseases
| Article | Year |
|---|---|
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Administ | 2001 |
Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
Topics: Administration, Oral; Adolescent; Child; Child, Preschool; Cholinergic Antagonists; Drug Administrat | 2018 |
2 other studies available for oxybutynin and Nervous System Diseases
| Article | Year |
|---|---|
Spectrum of central anticholinergic adverse effects associated with oxybutynin: comparison of pediatric and adult cases.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Central Nervous System; Chi | 2009 |
Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cholinergic Antagonists; Drug Prescriptions; Drug Uti | 2001 |